AST SpaceMobile (ASTS) faced a severe setback as its BlueBird 7 satellite was placed into an incorrect orbit during a launch on April 19, 2026, leading to a significant stock decline. The satellite, launched aboard Blue Origin's New Glenn-3 rocket from Kennedy Space Center, was intended to be a key technology validation milestone for the company's direct-to-device broadband service. However, the payload was placed into a "too-low" or "off-nominal" orbit, rendering it inoperable. AST SpaceMobile confirmed the satellite would be de-orbited to burn up in Earth's atmosphere.
The financial loss from the satellite is expected to be covered by insurance, but the time loss is a critical blow. The company needs between 45 and 60 satellites operational to offer commercial service in northern latitudes but currently has only six in orbit. It still targets having around 45 satellites in orbit by the end of 2026, a timeline now under greater pressure.
This failure compounds existing investor concerns. The stock dropped roughly 14% in premarket trading on Monday, April 20, following the news, adding to a previous 6% drop the prior week. That earlier decline was triggered by a wave of insider selling, including Rakuten billionaire Hiroshi Mikitani selling 1.69 million shares for approximately $154.5 million on April 14. Total insider sales last quarter reached around $274 million. Additionally, the company's CTO, Huiwen Yao, sold 90% of his position in March.
The competitive landscape is intensifying. Analysts cited pressure from Amazon's announced acquisition of Globalstar, which targets the same direct-to-device market from 2028. Furthermore, SpaceX's Starlink continues its rapid expansion, having launched over a thousand satellites in 2026 alone and securing carrier deals in regions where AST has agreements.
Following the launch failure and competitive concerns, analyst sentiment turned more bearish. Deutsche Bank cut its price target from $139 to $117, while Scotiabank analyst Andres Coello downgraded the stock to "Sector Underperform" with a $41.20 target, implying a further 52% downside from pre-failure levels. The consensus analyst rating is now "Reduce" with an average price target of $77.10.
Despite the sell-off, some institutional investors like Vanguard and Invesco increased their stakes in the previous quarter. The company reported Q4 2025 revenue of $54.31 million, beating estimates, and provided 2026 revenue guidance of $150 million to $200 million.
